Emma F, Hoff WV, Hohenfellner K, Topaloglu R, Greco M, Ariceta G, Bettini C, Bockenhauer D, Veys K, Pape L, Hulton S, Collin S, Ozaltin F, Servais A, Deschenes G, Novo R, Bertholet-Thomas A, Oh J, Cornelissen E, Janssen M, Haffner D, Rava L, Antignac C, Devuyst O, Niaudet P, Levtchenko E (2021) An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis
BPC-157 is a research compound derived from gastric protective protein, not FDA or EMA approved for therapeutic indications
The Endocrine Society's 2011 clinical practice guideline on adult growth hormone deficiency recommends maintaining IGF-1 at 0 to +2 SDS for age
10.1007/s11010-020-03821-8 46
It occurs gradually as inflammation is reduced and tissue repair mechanisms take effect